0 Commenti
0 condivisioni
256 Views
0 Anteprima
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
-
Effettua l'accesso per mettere mi piace, condividere e commentare!
-
Global Tardive Dyskinesia Market Insights & Growth Trends | CAGR 10.4% (2025–2031)According to a newly published market research report by 24LifeSciences, global tardive dyskinesia market was valued at USD 483.6 million in 2024 and is projected to reach USD 970.2 million by 2031, growing at a compound annual growth rate (CAGR) of 10.4% during the forecast period 20252031. Tardive dyskinesia (TD), a serious neurological movement disorder, is characterized by involuntary,...0 Commenti 0 condivisioni 502 Views 0 Anteprima
-
Tardive Dyskinesia Treatment Market Growth, Neurological Disorder Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the Taste Enhancers Market The global taste enhancers market size was valued at USD 2.99 billion in 2024 and is expected to reach USD 4.32 billion by 2032, at a CAGR of 4.70% during the forecast period Getting thoughtful about competitive landscape is another significant aspect of...0 Commenti 0 condivisioni 237 Views 0 Anteprima
-
Tardive Dyskinesia Treatment Market Size, Neurological Disorder Therapy Trends and Forecast"According to the latest report published by Data Bridge Market Research, the Tardive Dyskinesia Treatment Market The global tardive dyskinesia treatment market size was valued at USD 324.82 million in 2024 and is expected to reach USD 452.12 million by 2032, at a CAGR of 4.22% during the forecast period Global Tardive Dyskinesia Treatment Market document...0 Commenti 0 condivisioni 293 Views 0 Anteprima
-
VMAT2 Inhibitor Market: How Is Tardive Dyskinesia Becoming the Fastest-Growing Indication Driving Prescription Volume?Tardive dyskinesia treatment with VMAT2 inhibitors — the vesicular monoamine transporter 2 blockade for drug-induced involuntary movement suppression representing the fastest-growing indication in the global VMAT2 inhibitor market — creates the most clinically significant market segment, with the VMAT2 Inhibitor Market reflecting tardive dyskinesia as the premium volume commercial...0 Commenti 0 condivisioni 314 Views 0 Anteprima